Back to Search Start Over

Letter by Tampaki et al Regarding Article, 'Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)'

Authors :
Tampaki, E.C. Tampakis, A. Pantos, C.
Publication Year :
2018

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.od......2127..6fcee96769b1e952eb3ee41d4dbbf7b5